España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
EyePoint Pharmaceuticals
EYPT
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$8.80
-0.05
-0.56%
At Close: -
$8.80
0
0.00%
After Hours: Jul 19, 4:00 PM EDT
15 minutes delayed
Get Report
Comment
EyePoint Pharmaceuticals (EYPT) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for EyePoint Pharmaceuticals (NASDAQ:EYPT) Stock
EyePoint Pharmaceuticals Stock (NASDAQ: EYPT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, July 12, 2024
Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday
Avi Kapoor
Friday, June 28, 2024
Chardan Capital Maintains Buy on EyePoint Pha...
Benzinga Newsdesk
Thursday, June 27, 2024
HC Wainwright & Co. Reiterates Buy on EyePoin...
Benzinga Newsdesk
Wednesday, June 26, 2024
EyePoint Pharmaceuticals To Highlight DURAVYU...
Benzinga Newsdesk
Thursday, June 20, 2024
Cantor Fitzgerald Reiterates Overweight on Ey...
Benzinga Newsdesk
Tuesday, June 04, 2024
JP Morgan Maintains Overweight on EyePoint Ph...
Benzinga Newsdesk
Monday, May 13, 2024
Crocs To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday
Avi Kapoor
HC Wainwright & Co. Maintains Buy on EyePoint...
Benzinga Newsdesk
Wednesday, May 08, 2024
EyePoint Pharmaceuticals' Q1 Cash And Investm...
Benzinga Newsdesk
EyePoint Pharmaceuticals Q1 2024 GAAP EPS $(0...
Benzinga Newsdesk
Baird Maintains Outperform on EyePoint Pharma...
Benzinga Newsdesk
Flywire Reports Q1 Loss, Joins ZoomInfo, Inspire Medical Systems And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
Tuesday, May 07, 2024
Deep Dive Into EyePoint Pharmaceuticals Stock: Analyst Perspectives (4 Ratings)
Benzinga Insights
Chardan Capital Maintains Buy on EyePoint Pha...
Benzinga Newsdesk
Mizuho Maintains Buy on EyePoint Pharmaceutic...
Benzinga Newsdesk
Monday, May 06, 2024
Dow Surges Over 100 Points; EyePoint Pharmaceuticals Shares Plunge
Avi Kapoor
Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday
Avi Kapoor
Crude Oil Gains 1%; TreeHouse Foods Shares Fall After Q1 Results
Avi Kapoor
Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Nasdaq Jumps 100 Points; Tyson Foods Sales Miss Views
Avi Kapoor
EyePoint Pharmaceuticals Shares Halted On Cir...
Benzinga Newsdesk
Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday?
Vandana Singh
Market-Moving News for May 6th
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
EyePoint Pharmaceuticals shares are trading l...
Benzinga Newsdesk
EyePoint Pharmaceuticals Announces Announces ...
Benzinga Newsdesk
Trading Halt: Halt status updated at 7:25:00 ...
Benzinga Newsdesk
EyePoint Pharmaceuticals Announces Topline Da...
Benzinga Newsdesk
Trading Halt: Halted at 6:55:38 a.m. ET - Tra...
Benzinga Newsdesk
Tuesday, April 23, 2024
Over $10M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
Avi Kapoor
Friday, March 08, 2024
Critical Insights From EyePoint Pharmaceuticals Analyst Ratings: What You Need To Know
Benzinga Insights
HC Wainwright & Co. Maintains Buy on EyePoint...
Benzinga Newsdesk
Thursday, March 07, 2024
Eyepoint Pharmaceuticals Expect That Cash, Ca...
Benzinga Newsdesk
EyePoint Pharmaceuticals Q4 GAAP EPS $(0.33) ...
Benzinga Newsdesk
Earnings Scheduled For March 7, 2024
Benzinga Insights
Wednesday, March 06, 2024
A Preview Of EyePoint Pharmaceuticals's Earnings
Benzinga Insights
Monday, March 04, 2024
Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday
Avi Kapoor
Friday, February 16, 2024
Mizuho Maintains Buy on EyePoint Pharmaceutic...
Benzinga Newsdesk
Monday, February 12, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Sunday, February 04, 2024
EyePoint Pharmaceuticals Says The Trial Met I...
Benzinga Newsdesk
EyePoint Pharmaceuticals Announces Two Presen...
Benzinga Newsdesk
Monday, January 22, 2024
Unveiling 7 Analyst Insights On EyePoint Pharmaceuticals
Benzinga Insights
JP Morgan Initiates Coverage On EyePoint Phar...
Benzinga Newsdesk
Tuesday, January 16, 2024
HC Wainwright & Co. Maintains Buy on EyePoint...
Benzinga Newsdesk
Friday, January 12, 2024
$30M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
Avi Kapoor
Thursday, January 11, 2024
Form 4 Shows Cormorant Global Healthcare Mast...
Benzinga Newsdesk
Wednesday, January 10, 2024
EyePoint Says First Patient Has Been Dosed In...
Benzinga Newsdesk
Tuesday, December 19, 2023
Russell 2000 Rallies To 16-Month Highs: Best Performing Small-Cap Stocks Popping Over 80% In December
Piero Cingari
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch